China Expands Global Pharma Access Through Healthcare Reforms
China's National Healthcare Security Administration supports the development of cross-border pharmaceutical trading platforms to reduce the cost of procuring Chinese pharmaceutical products in Southeast Asia, Central Asia, and other regions. By integrating online and offline centralized procurement systems, the initiative promotes the globalization of domestically produced pharmaceuticals and medical devices, enhances the international competitiveness of China's pharmaceutical industry, and benefits more developing countries. This aims to provide affordable and quality healthcare products to a wider population.
